These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic relevance of masked hypertension in subjects with prehypertension. Pierdomenico SD, Pannarale G, Rabbia F, Lapenna D, Licitra R, Zito M, Campanella M, Gaudio C, Veglio F, Cuccurullo F. Am J Hypertens; 2008 Aug; 21(8):879-83. PubMed ID: 18464744 [Abstract] [Full Text] [Related]
3. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D, American Heart Association, American Society of Hypertension, Preventive Cardiovascular Nurses Association. J Cardiovasc Nurs; 2008 Aug; 23(4):299-323. PubMed ID: 18596492 [Abstract] [Full Text] [Related]
4. Masked hypertension: evaluation, prognosis, and treatment. Angeli F, Reboldi G, Verdecchia P. Am J Hypertens; 2010 Sep; 23(9):941-8. PubMed ID: 20508623 [Abstract] [Full Text] [Related]
5. In clinical practice, masked hypertension is as common as isolated clinic hypertension: predominance of younger men. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Am J Hypertens; 2005 May; 18(5 Pt 1):589-93. PubMed ID: 15882539 [Abstract] [Full Text] [Related]
6. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study. Shimada K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimamoto K, Tanaka H, Yoshiike N. Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598 [Abstract] [Full Text] [Related]
7. Routine use of ambulatory blood pressure monitoring in potential living kidney donors. Ommen ES, Schröppel B, Kim JY, Gaspard G, Akalin E, de Boccardo G, Sehgal V, Lipkowitz M, Murphy B. Clin J Am Soc Nephrol; 2007 Sep; 2(5):1030-6. PubMed ID: 17702722 [Abstract] [Full Text] [Related]
8. Home blood pressure measurement and its relationship with blood pressure control in a large selected hypertensive population. Cuspidi C, Meani S, Fusi V, Salerno M, Valerio C, Severgnini B, Catini E, Leonetti G, Magrini F, Zanchetti A. J Hum Hypertens; 2004 Oct; 18(10):725-31. PubMed ID: 15103315 [Abstract] [Full Text] [Related]
9. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Naser N, Dzubur A, Durak A, Kulic M, Naser N. Med Arch; 2016 Jul 27; 70(4):274-279. PubMed ID: 27703288 [Abstract] [Full Text] [Related]
10. Determinants of masked hypertension in the general population: the Finn-Home study. Hänninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. J Hypertens; 2011 Oct 27; 29(10):1880-8. PubMed ID: 21841499 [Abstract] [Full Text] [Related]
11. The clinical significance of white-coat and masked hypertension. Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, Reboldi G. Blood Press Monit; 2007 Dec 27; 12(6):387-9. PubMed ID: 18277317 [Abstract] [Full Text] [Related]
12. High prevalence of masked hypertension in treated hypertensive patients with type 2 diabetes mellitus. Alsuwaida A, Parkes R, So J, Feig D, Logan A. Saudi J Kidney Dis Transpl; 2006 Sep 27; 17(3):326-37. PubMed ID: 16970252 [Abstract] [Full Text] [Related]
13. Masked hypertension: different blood pressure measurement methodology and risk factors in a working population. Trudel X, Brisson C, Larocque B, Milot A. J Hypertens; 2009 Aug 27; 27(8):1560-7. PubMed ID: 19444141 [Abstract] [Full Text] [Related]
14. Prevalence of Masked Hypertension in Subjects Treated with Antihypertensive Drugs as Assessed by Morning versus Evening Home Blood Pressure Measurements: the J-HOME study. Obara T, Ohkubo T, Asayama K, Kikuya M, Metoki H, Inoue R, Komai R, Murai K, Hashimoto J, Totsune K, Imai Y, J-Home Study Group. Clin Exp Hypertens; 2008 Apr 27; 30(3):277-87. PubMed ID: 18425707 [Abstract] [Full Text] [Related]
15. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Int J Cardiol; 2007 May 02; 117(3):355-9. PubMed ID: 16879886 [Abstract] [Full Text] [Related]
16. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. Gaborieau V, Delarche N, Gosse P. J Hypertens; 2008 Oct 02; 26(10):1919-27. PubMed ID: 18806615 [Abstract] [Full Text] [Related]
17. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. J Hypertens; 2008 Apr 02; 26(4):699-705. PubMed ID: 18327079 [Abstract] [Full Text] [Related]
18. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population. Wang GL, Li Y, Staessen JA, Lu L, Wang JG. J Hypertens; 2007 Dec 02; 25(12):2398-405. PubMed ID: 17984660 [Abstract] [Full Text] [Related]
19. Tom Pickering as a clinical scientist: masked hypertension. Eguchi K. Blood Press Monit; 2010 Apr 02; 15(2):85-9. PubMed ID: 20404601 [Abstract] [Full Text] [Related]